Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder
Clinical trial NCT02660528 · TERMINATED
Trial details
- NCT number
- NCT02660528
- Sponsor
- Brigham and Women's Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2020-06-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.